Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

about

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

Item

http://www.wikidata.org/entity/Q41080080

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Maintenance therapy with alter ...... ase II multicentre FILO trial.

@en

type

Item

label

Maintenance therapy with alter ...... ase II multicentre FILO trial.

@en

prefLabel

Maintenance therapy with alter ...... ase II multicentre FILO trial.

@en

P1476

Maintenance therapy with alter ...... hase II multicentre FILO trial

@en

P2093

A Banos

http://www.w3.org/2001/XMLSchema#string

A Pigneux

http://www.w3.org/2001/XMLSchema#string

A Saad

http://www.w3.org/2001/XMLSchema#string

A Schmidt-Tanguy

http://www.w3.org/2001/XMLSchema#string

B Choufi

http://www.w3.org/2001/XMLSchema#string

C Bonmati

http://www.w3.org/2001/XMLSchema#string

C Himberlin

http://www.w3.org/2001/XMLSchema#string

C Recher

http://www.w3.org/2001/XMLSchema#string

E Daguindau

http://www.w3.org/2001/XMLSchema#string

E Tavernier

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.

Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?

High-dose daunorubicin in older patients with acute myeloid leukemia.

Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.

Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.

Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study.

Efficacy of the hypomethylating agents as frontline, salvage, or consolidation therapy in adults with acute myeloid leukemia (AML).

Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).

A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission.

Addition of Androgens Improves Survival in Elderly Patients With Acute Myeloid Leukemia: A GOELAMS Study.

P2888

bcj.2017.50

P304

e568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BCJ.2017.50

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085742026

http://www.w3.org/2001/XMLSchema#string

P698

28574488

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

multicenter trial

P932

5520397

http://www.w3.org/2001/XMLSchema#string